Pharma groups slam US decision to support COVID-19 vaccine patent waivers
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaRegulatory Intelligence/PolicyResearch, Design and Development